These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9810132)

  • 21. Consensus on infertility treatment related to polycystic ovary syndrome.
    Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group
    Fertil Steril; 2008 Mar; 89(3):505-22. PubMed ID: 18243179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obesity does not adversely affect results in patients who are undergoing in vitro fertilization and embryo transfer.
    Dechaud H; Anahory T; Reyftmann L; Loup V; Hamamah S; Hedon B
    Eur J Obstet Gynecol Reprod Biol; 2006 Jul; 127(1):88-93. PubMed ID: 16417960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of female increased body mass index on in vitro fertilization cycles outcome.
    Caillon H; Fréour T; Bach-Ngohou K; Colombel A; Denis MG; Barrière P; Masson D
    Obes Res Clin Pract; 2015; 9(4):382-8. PubMed ID: 25769458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome.
    Heijnen EM; Eijkemans MJ; Hughes EG; Laven JS; Macklon NS; Fauser BC
    Hum Reprod Update; 2006; 12(1):13-21. PubMed ID: 16123051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obesity and poor reproductive outcome: the potential role of the endometrium.
    Bellver J; Melo MA; Bosch E; Serra V; Remohí J; Pellicer A
    Fertil Steril; 2007 Aug; 88(2):446-51. PubMed ID: 17418840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving reproductive performance in overweight/obese women with effective weight management.
    Norman RJ; Noakes M; Wu R; Davies MJ; Moran L; Wang JX
    Hum Reprod Update; 2004; 10(3):267-80. PubMed ID: 15140873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Body mass index, protein metabolism profiles and impact on IVF/ICSI procedure and outcome].
    Munz W; Fischer-Hammadeh C; Herrmann W; Georg T; Rosenbaum P; Schmidt W; Hammadeh ME
    Zentralbl Gynakol; 2005 Feb; 127(1):37-42. PubMed ID: 15702449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of body mass index to in-vitro fertilisation treatment outcome, risk of miscarriage and pregnancy outcome.
    Thum MY; El-Sheikhah A; Faris R; Parikh J; Wren M; Ogunyemi T; Gafar A; Abdalla H
    J Obstet Gynaecol; 2007 Oct; 27(7):699-702. PubMed ID: 17999296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follicular aspiration during the selection phase prevents severe ovarian hyperstimulation in patients with polycystic ovary syndrome who are undergoing in vitro fertilization.
    Zhu WJ; Li XM; Chen XM; Zhang L
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):79-84. PubMed ID: 16154042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison study of a novel stimulation protocol and the conventional low dose step-up and step-down regimens in patients with polycystic ovary syndrome undergoing in vitro fertilization.
    Koundouros SN
    Fertil Steril; 2008 Sep; 90(3):569-75. PubMed ID: 17880950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of body mass index on assisted reproduction.
    Tamer Erel C; Senturk LM
    Curr Opin Obstet Gynecol; 2009 Jun; 21(3):228-35. PubMed ID: 19395966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
    Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
    Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leptin and ovarian folliculogenesis: implications for ovulation induction and ART outcomes.
    Brannian JD; Hansen KA
    Semin Reprod Med; 2002 May; 20(2):103-12. PubMed ID: 12087495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Female obesity and assisted reproductive technologies.
    Kumbak B; Oral E; Bukulmez O
    Semin Reprod Med; 2012 Dec; 30(6):507-16. PubMed ID: 23074009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlled ovarian hyperstimulation: does prolonged stimulation justify cancellation of in vitro fertilization cycles?
    Bar-Hava I; Yoeli R; Yulzari-Roll V; Ashkenazi J; Shalev J; Orvieto R
    Gynecol Endocrinol; 2005 Oct; 21(4):232-4. PubMed ID: 16316846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the relationship between follicular fluid oxidative stress, ovarian hormones, and response to gonadotropin stimulation.
    Appasamy M; Jauniaux E; Serhal P; Al-Qahtani A; Groome NP; Muttukrishna S
    Fertil Steril; 2008 Apr; 89(4):912-21. PubMed ID: 17681319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obesity and infertility.
    Pasquali R; Patton L; Gambineri A
    Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):482-7. PubMed ID: 17982356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the oral contraceptive pill on patients undergoing controlled ovarian hyperstimulation.
    Frederick J; DaCosta V; Wynter S; Reid M; Frederick C; McKenzie C
    West Indian Med J; 2004 Jan; 53(1):39-43. PubMed ID: 15114893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Impact of overweight on the outcome of ovarian stimulation].
    Hugues JN
    Bull Acad Natl Med; 2008 Apr; 192(4):661-70; discussion 670-1. PubMed ID: 19024938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of low response to mild ovarian stimulation initiated on cycle day 5 for IVF.
    Verberg MF; Eijkemans MJ; Macklon NS; Heijnen EM; Fauser BC; Broekmans FJ
    Hum Reprod; 2007 Jul; 22(7):1919-24. PubMed ID: 17485438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.